Articles

Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment

Division of Hematology, Ospedale degli Infermi, Biella, Italy;
Hemato-Oncology Department, Saint Louis Hospital, Paris, France;
Institute of Oncology Research, Bellinzona, Switzerland;
Clinical Research Methodology Laboratory, IRCCS Mario Negri Institute, Milan, Italy;
Division of Oncology, Department of Internal Medicine I, Medical University of Vienna,Vienna,Austria;
Division of Hematology, Dept. of Translational Medicine, University of Eastern Piedmont,Novara,Italy;
Division of Hematology, Dept. of Translational Medicine, University of Eastern Piedmont,Novara,Italy;
Division of Oncology, Department of Internal Medicine I, Medical University of Vienna,Vienna,Austria;
Institute of Oncology Research, Bellinzona, Switzerland;
Department of Hematology, Hospital Clinic, Barcelona, Spain;
Cancer Research UK Center, Southampton General Hospital, Southampton, United Kingdom;
Division of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Haematologica Early view Jan 2, 2020 https://doi.org/10.3324/haematol.2019.237990